Clincosm LogoSign in Get a demo

SARS-CoV-2

Showing 76 - 100 of 246
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19, SARS-CoV-2 Trial in Chile, Peru, United States (AZD1222, Placebo)

Active, not recruiting
Has Results
  • COVID-19
  • SARS-CoV-2
  • AZD1222
  • Placebo
  • Phoenix, Arizona
  • +83 more
Jul 13, 2022

SARS-CoV-2, COVID-19, Mouthwashes Trial in Jeddah (Distilled Water, 1% Povidone Iodine (PVP-I), 1.5% Hydrogen Peroxide (H2O2))

Completed
  • SARS-CoV-2
  • +7 more
  • Distilled Water
  • +5 more
  • Jeddah, Saudi Arabia
    Alhamra TETAMMAN clinic (PHC)
Jul 18, 2022

SARS-CoV-2 Trial in Changsha, Xiangtan (SARS-CoV-2 (LVRNA009) 50µg group, SARS-CoV-2 (LVRNA009) 100µg group, Placebo)

Active, not recruiting
  • SARS-CoV-2
  • SARS-CoV-2 (LVRNA009) 50μg group
  • +2 more
  • Changsha, Hunan, China
  • +1 more
Jul 19, 2022

SARS-CoV-2 Trial in Los Angeles (Family Risk Messaging, Personal Risk Messaging, Loss Protection)

Enrolling by invitation
  • SARS-CoV-2
  • Family Risk Messaging
  • +3 more
  • Los Angeles, California
    AltaMed Health
Jul 12, 2022

COVID-19, SARS-CoV-2 Trial in Puerto Rico, United States (Abatacept, Placebo)

Terminated
  • COVID-19
  • SARS-CoV-2
  • Abatacept
  • Placebo
  • Hialeah, Florida
  • +9 more
Jul 6, 2022

SARS-CoV-2 Trial in Singapore (ARCT-021)

Terminated
  • SARS-CoV-2
  • ARCT-021
  • Singapore, Singapore
    SingHealth Investigational Medicine Unit (IMU), Singapore Genera
Jul 7, 2022

SARS-CoV-2 Trial in Beijing (1 week (Week 1), 1 week of probiotics(Week 1), 1 week (Week 2))

Recruiting
  • SARS-CoV-2
  • 1 week placebo(Week 1)
  • +5 more
  • Beijing, China
  • +1 more
Jul 3, 2022

SARS-CoV-2 Trial in Beijing (Probiotics daily, Placebo daily)

Completed
  • SARS-CoV-2
  • Probiotics daily
  • Placebo daily
  • Beijing, China
  • +1 more
Jul 3, 2022

COVID-19 Vaccination and Breakthrough Infections Among Persons

Completed
  • Immunocompromised
  • +5 more
  • BNT162b2 (Tozinameran)
  • New York, New York
    Pfizer Inc.
Jul 1, 2022

SARS-CoV-2 Trial in United States (REGN14256, imdevimab, casirivimab + imdevimab)

Completed
  • SARS-CoV-2
  • La Mesa, California
  • +27 more
Jul 5, 2022

SARS-CoV-2 Trial in New York (Sodium Chloride, NDV-HXP-S IN low dose, NDV-HXP-S IM low dose)

Recruiting
  • SARS-CoV-2
  • Sodium Chloride
  • +4 more
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Jun 30, 2022

COVID-19, SARS-CoV-2 Trial in Worldwide (AZD1222, AZD2816)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2
  • AZD1222
  • AZD2816
  • Brasilia, Brazil
  • +34 more
Jun 27, 2022

COVID-19, SARS-CoV-2 Trial in Johannesburg, Pretoria (GRT-R912, samRNA-Spikebeta-TCE11, GRT-R914, samRNA-Spikebeta-TCE9,

Recruiting
  • COVID-19
  • SARS-CoV-2
  • GRT-R912, samRNA-Spikebeta-TCE11
  • +2 more
  • Johannesburg, South Africa
  • +1 more
Jun 24, 2022

SARS-CoV-2 Trial in Islamabad (LVRNA009, CoronaVac®)

Not yet recruiting
  • SARS-CoV-2
  • LVRNA009
  • CoronaVac®
  • Islamabad, Pakistan
    Clinical Trial Unit, National Institute of Health
Jun 22, 2022

SARS-CoV-2 Trial (ACE2 Chewing Gum, Placebo Chewing Gum)

Not yet recruiting
  • SARS-CoV-2
  • ACE2 Chewing Gum
  • Placebo Chewing Gum
  • (no location specified)
Jun 24, 2022

Within Household Transmission of COVID-19 Infections

Completed
  • SARS-CoV-2
  • No intervention
  • Utrecht, Netherlands
    UMC Utrecht
Jun 23, 2022

Covid19, SARS-CoV-2 Trial in Worldwide (CVnCoV, Placebo, Authorized/licensed vaccines for preventing COVID-19 (AV))

Completed
  • Covid19
  • SARS-CoV-2
  • CVnCoV
  • +2 more
  • Buenos Aires, Argentina
  • +45 more
Jun 20, 2022

COVID-19, SARS-CoV-2 Trial in Aulnay-sous-Bois (Rapid Diagnostic Test vs PCR)

Terminated
  • COVID-19
  • SARS-CoV-2
  • Rapid Diagnostic Test vs PCR
  • Aulnay-sous-Bois, France
    CHI Robert Ballanger
Jun 13, 2022

St. Jude Tracking of Viral and Host Factors Associated With

Recruiting
  • COVID-19
  • +3 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jun 7, 2022

    Immunological Profiling of COVID-19 in Respiratory Distress

    Recruiting
    • SARS-CoV-2
    • Covid-19
    • Immunological profiling
    • Nîmes, France
      CHU de Nimes
    Jun 2, 2022

    SARS-CoV-2, Seasonal Influenza, Respiratory Syncytial Virus Trial in United States (mRNA-1273, mRNA-1010, mRNA-1345)

    Recruiting
    • SARS-CoV-2
    • +3 more
    • mRNA-1273
    • +4 more
    • Hollywood, Florida
    • +7 more
    May 25, 2022

    HIV/AIDS, COVID-19, SARS-CoV-2 Trial in Columbia (No intervention)

    Completed
    • HIV/AIDS
    • +2 more
    • No intervention
    • Columbia, Missouri
      University of Missouri-Columbia
    May 16, 2022

    Myocardial Injury, Myocarditis, COVID-19 Vaccination Trial in Toronto (Cardiac PET/MRI, Blood Biomarkers)

    Recruiting
    • Myocardial Injury
    • +4 more
    • Cardiac PET/MRI
    • Blood Biomarkers
    • Toronto, Ontario, Canada
      University Health Network
    May 16, 2022

    Covid-19 Infection Rates in Healthcare Workers

    Active, not recruiting
    • SARS-CoV-2
      • Bern, Switzerland
        Guido Beldi
      May 17, 2022

      Potential Airborne Transmission and Protective Value of Type II

      Completed
      • SARS-CoV-2
        • Bern, Switzerland
          University Hospital Bern
        May 17, 2022